Real-World Study Shows OneTouch Reveal® Plus Digital Coach Drives Positive Health Outcomes

24/7 digital coaching tool impacted self-care behaviors,A ER visits for people with Type 2 diabetes, and healthcare costs for health plan MALVERN, Pa. and COLUMBIA, Md., Aug. 13, 2020 /CNW/ --A LifeScan, a world leader in blood glucose monitoring and maker of the iconic OneTouchA® brand, and Welldoc, maker of the first FDA-cleared, 510(K) Software as a Medical Device (SaMD) for Diabetes, today announced the findings of a real-world, observational study conducted with a large, national payor at the Association of Diabetes Care and Education Specialists (DCES) conference and, through a Letter to the Editor, published in the Journal of Diabetes Science and Technology (JDST).The study findings show people with type 2 diabetes who used LifeScan's OneTouch RevealA® Plus app, powered by Welldoc's BlueStarA®, saw improved health outcomes with clinically significant reductions in A1C lab values and average blood glucose levels after three and six months. The study revealed that participants who used the 24/7 digital coaching tool with AI technology demonstrated:

Strong engagement

Increase in self-care behaviors

Reduction in diabetes related and all-cause ER visits

The study included 291 payor members, who were provided with the OneTouch Reveal Plus app and a OneTouch Verio FlexA® meter to sync blood glucose results.A  Study results correlated strong engagement with members averaging 30 engagements per week.A  The study results also showed A1C reductions, specifically 0.54 average reduction in A1C across all starting A1C ranges (n=35, p=0.021) and 1.83 average reduction in A1C for A1C>8 (n=12, p=0.002).A  Additional observational data included reductions in average ER diabetes-related member costs by 55%, and average ER diabetes-related member visits by 30%. *
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Сентябрь 2020    »